Page 89 - Read Online
P. 89

Page 8 of 9                                Lo Re et al. J Cancer Metastasis Treat 2020;6:17  I  http://dx.doi.org/10.20517/2394-4722.2020.11

               Availability of data and materials
               The source of the data is PUBMED and proceeding ASCO.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Informed consent to treatment was accepted and signed by the patient after ethical approval by the
               competent facility.

               Consent for publication
               Patient consent for publication.


               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
                   mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
               2.   Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations,
                   1978-2012: empirical relationships. JAMA Dermatol 2014;150:1063-71.
               3.   del Pino M, Bleeker MC, Quint WG, Snijders PJ, Meijer CJ, et al. Comprehensive analysis of human papillomavirus prevalence and the
                   potential role of low-risk types in verrucous carcinoma. Mod Pathol 2012;25:1354-63.
               4.   Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a
                   highly malignant subtype of skin cancer. Cancer 1997;79:915-9.
               5.   Azorín D, López-Ríos F, Ballestín C, Barrientos N, Rodríguez-Peralto JL. Primary cutaneous adenosquamous carcinoma: a case report
                   and review of the literature. J Cutan Pathol 2001;28:542-5.
               6.   van der Waal I, Reichart PA. Oral proliferative verrucous leukoplakia revisited. Oral Oncol 2008;44:719-21.
               7.   Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis,
                   and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016;152:419-28.
               8.   Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, et al. A new American Joint Committee on cancer staging system for cutaneous
                   squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9.
               9.   Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural
                   invasion: an 11-year cohort study. JAMA Dermatol 2013;149:35-41.
               10.  Puza CJ, Beasley GM, Barbas AS, Mosca PJ. Type of organ transplanted impacts the risk and presentation of cutaneous squamous cell
                   carcinoma in transplant recipients. Exp Clin Transplant 2020;18:93-7.
               11.  Quaglino P, Nardò T, Fierro MT, Massaia M, Orsucci L, et al. Clinicopathologic spectrum of cutaneous diseases in patients with
                   hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. G Ital
                   Dermatol Venereol 2013;148:453-63.
               12.  Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, et al. Association of nonmelanoma skin cancer with second malignancy.
                   Cancer 2004;100:130-8.
               13.  Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, et al. A multi-institutional comparison of outcomes of immunosuppressed
                   and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
                   Cancer 2017;123:2054-60.
               14.  Trodello C, Pepper JP, Wong M, Wysong A. Cisplatin and cetuximab treatment for metastatic cutaneous squamous cell carcinoma: a
                   systematic review. Dermatol Surg 2017;43:40-9.
               15.  FitzGerald GB, Wick MM. Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and
                   methotrexate on human squamous cell carcinoma. J Invest Dermatol 1987;88:66-70.
               16.  Gil S, Yébenes M, Luelmo J, Alsina M, Sabés M. A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous
                   squamous human carcinoma cell line: potential chemotherapy alternative to surgery. Dermatol Ther 2016;29:341-4.
               17.  Hitt R, Jimeno A, Rodríguez-Pinilla M, Rodríguez-Peralto JL, Millán JM, et al. Phase II trial of cisplatin and capecitabine in patients with
                   squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors. Br J Cancer 2004;91:2005-11.
   84   85   86   87   88   89   90   91   92   93   94